RECRUITING Not applicable ClinicalTrials.gov

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

Sponsor: SWOG Cancer Research Network • ClinicalTrials.gov ID: NCT07278739

Registry updated: 2026-10-09

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

This clinical trial evaluates an educational program called Algorithm-Enabled Patients Activated in Cancer Care Through Teams (A-PACT) for reducing unplanned hospital visits and improving goals of care conversations with providers among patients with solid cancers. A-PACT is an educational program where lay health workers (educators) help patients talk with their health care team about issues that matter most to them (goals of care). During A-PACT sessions, patients receive assistance in formulating health care and end of life care preferences, assistance in completing advance directives, guidance on how to engage in these conversations with family members, friends, and clinical teams, and encouragement to discuss these topics with their clinical team. A-PACT may reduce unplanned hospital visits and improve goals of care communication with providers among patients with solid cancers.

Interventions

Best Practice (Other)
Receive usual care
Educational Intervention (Other)
Receive A-PACT education
Electronic Health Record Review (Other)
Ancillary studies
Interview (Other)
Ancillary studies
Questionnaire Administration (Other)
Ancillary studies
Telephone-Based Intervention (Behavioral)
Receive A-PACT phone calls

Eligibility criteria

Inclusion Criteria: * Participants must have a diagnosis of a solid tumor malignancy of any stage * Participants must be identified as high risk, defined as having 6 month mortality estimate from machine learning (ML) algorithm \>= 20% * Participants must not be receiving or have pre-existing plans to enter hospice care at the time of study registration * Participant must be actively receiving or planning to receive systemic anti-cancer therapy (defined as any oral, injection, or intravenous therapy against cancer) within 3 months after registration * NOTE: This includes chemotherapy (conventional or cytotoxic chemotherapy), hormone therapy, targeted therapy, and immunotherapy * NOTE: Participants are allowed to be co-enrolled on other clinical trials including trials using investigational agents * Participants must be \>= 18 years of age at the time of study enrollment * Participants who can complete Patient Reported Outcome (PRO) questionnaires in English or Spanish must be willing to 1) complete PROs at all scheduled assessments; and 2) complete the pre-registration (baseline) PRO forms within 14 days prior to registration * Participants must be able to provide a valid telephone number for the purpose of being contacted by the lay health worker * NOTE: As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system * Patient and clinician participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines. This protocol does not permit use of Legally Authorized Representative NOTE: For this study, in the OPEN registration, clinician participants will be listed as their own treating investigator. However, clinician participants must not consent themselves or sign their own eligibility criteria forms

Conditions

Malignant Solid Neoplasm

Locations

CARTI Cancer Center — Little Rock, Arkansas, United States
Queen's Medical Center — Honolulu, Hawaii, United States
Carle at The Riverfront — Danville, Illinois, United States
Carle Physician Group-Effingham — Effingham, Illinois, United States
Carle Physician Group-Mattoon/Charleston — Mattoon, Illinois, United States
Carle Cancer Institute Normal — Normal, Illinois, United States
Carle Cancer Center — Urbana, Illinois, United States

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment